New challenges in blood pressure goals and assessment

Nature Reviews Cardiology

Volumn 8, Issue 2, 2011, Pages 74-75

  Oparil, Suzanne ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PRACTICE; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; HUMAN; HYPERTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; BLOOD PRESSURE; DRUG EFFECT; MORTALITY; PHYSIOLOGY;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION;

EID: 79251639178     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2010.201     Document Type: Review

References (9)

1. Cushman, W. C. et al. for the aCCOrD Study Group. effects of intensive blood-pressure control in type 2 diabetes mellitus. N. Engl. J. Med. 362, 1575-1585 (2010).
2. Cooper-DeHoff, R. M. et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 304, 61-68 (2010).
3. Sleight, P. et al. OnTarGeT investigators. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan alone and in combination with ramipril Global endpoint Trial study. J. Hypertens. 27, 1360-1369 (2009).
4. Turnbull, F. for the Blood Pressure Lowering Treatment Trialists' Collaboration. effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 362, 1527-1535 (2003).
5. Law, M. R., Morris, J. K. & Wald, N. J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338, b1665 (2009).
6. US Department of Health and Human Services. national Heart, Lung, and Blood institute, niH news. niH blood pressure trial expands to include more older adults [online] http://www.nih.gov/news/health/oct2010/nhlbi-04.htm (2010).
7. Rothwell, P. M. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 375, 938-948 (2010).
8. Rothwell, P. M. et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375, 895-905 (2010).
9. Webb, A. J., Fischer, U., Mehta, Z. & Rothwell, P. M. effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 375, 906-915 (2010).